AGIO Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Also see: AGIO Shares Outstanding History and AGIO YTD Return |
AGIO Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Also see: AGIO Shares Outstanding History and AGIO YTD Return |
AGIO Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
+5.40% CAGR ![]() Mouse over chart for data details
|
AGIO Stock Price Chart |
About Agios Pharmaceuticals Inc |
Agios Pharmaceuticals, Inc. is a biopharmaceutical company. Co. is focused on developing and delivering transformative therapies for patients living with rare diseases. It markets a first-in-class pyruvate kinase (PK) activator for adults with PK deficiency, the first disease-modifying therapy for debilitating hemolytic anemia. Its lead product candidate in its genetically defined disease (GDD) portfolio, PYRUKYND (Mitapivat), is an activator of both wild-type and a variety of mutant pyruvate kinase (PK) enzymes, for the treatment of hemolytic anemias. The Mitapivat is an orally available small molecule and a potent activator of the pyruvate kinase R (PKR) enzymes. We show 48 historical shares outstanding datapoints in our AGIO shares outstanding history coverage, used to compute AGIO market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing AGIO market cap history over the course of time is important for investors interested in comparing AGIO's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of AGIO versus a peer is one thing; comparing AGIO market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like AGIO can fluctuate over the course of history. With this page we aim to empower investors researching AGIO by allowing them to research the AGIO market cap history. |
AGIO Current Stock Quote |
![]() Get Dividend Alerts ![]() Get SEC Filing Alerts ![]() |
Video: The Importance of Market Cap | |
|
AGIO Share Performance |
Market Cap Peers |
Agios Pharmaceuticals (AGIO) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
AGL Market Cap History |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.